# Flying L Partners

Flying L Partners is a Private Equity based in Newport Beach, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Newport Beach, United States
- **Region:** North America
- **Address:** Newport Beach, CA, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** flyinglpartners.com
- **LinkedIn:** https://www.linkedin.com/company/flying-l-partners

## Regulatory record

- **Reports private funds:** No

## About

At Flying L Partners, we team with high-performance companies to bring capital and knowhow to accelerate innovation and value creation. With a focus primarily on the ophthalmic space, the principals in Flying L Partners have been involved in building, leading, and funding high impact technologies for over 30 years. Our mission is to create value for investors by bringing meaningful innovation to providers and patients to improve vision and treat diseases. We adhere to the principle that if it is better medicine and better business, then value will be created. When we do well, many people will benefit.

## Sectors

- Healthcare Services
- Medical Devices

## People

- William Link — Managing Partner
- Andy Corley — Partner
- Richard Lindstrom — Partner
- Matthew Larson — Administrative Partner
- Jeevan Gore — Chief Operating Officer

## Questions

### Who runs investment decisions at Flying L Partners?

Managing Partner William Link, alongside Partners Andy Corley and Richard Lindstrom, leads investment decisions. Link is a managing director of Versant Ventures and a serial founder of ophthalmology device companies; Corley previously co-founded and sold eyeonics; Lindstrom is a practicing surgeon at Minnesota Eye Consultants. The trio bring a mix of venture, operational, and clinical expertise to deal evaluation.

### Is Flying L Partners structured as a traditional venture fund?

No, the firm raises capital on a per-transaction basis. Once it identifies a single promising ophthalmic company, it forms a capital-raising effort dedicated to that asset. The model avoids a blind-pool fund structure, giving co-investors line-by-line exposure and allowing the firm to size each round to the specific clinical or regulatory milestone.

## Related profiles

- [Flying Kiwi Angels](https://altss.com/profile/flying-kiwi-angels)
- [Flyover Capital](https://altss.com/profile/flyover-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/flying-l-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology